BRIEF published on 07/09/2024 at 09:10, 2 months 10 days ago BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE published on 07/09/2024 at 09:05, 2 months 10 days ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations
BRIEF published on 06/20/2024 at 01:05, 2 months 29 days ago BioNxt Solutions Closes Second Tranche of Private Placement Private Placement Common Shares Warrants Research Funding BioNxt Solutions
BRIEF published on 06/20/2024 at 01:05, 2 months 29 days ago BioNxt Solutions clôture la deuxième tranche de placement privé Placement Privé Actions Ordinaires Bons De Souscription Financement De La Recherche Solutions BioNxt
PRESS RELEASE published on 06/20/2024 at 01:00, 2 months 29 days ago BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement BioNxt Solutions Inc. closes the second tranche of non-brokered private placement, raising $270,000. Proceeds will fund research, development, and working capital Private Placement Common Shares Working Capital Research And Development BioNxt Solutions Inc.
BRIEF published on 04/26/2024 at 05:55, 4 months 23 days ago BioNxt Solutions Advances Cladribine Studies and Announces Financing Initiative Private Placement BioNxt Solutions Inc. Multiple Sclerosis Cladribine Program Pharmaceutical Development
BRIEF published on 04/26/2024 at 05:55, 4 months 23 days ago BioNxt Solutions fait progresser les études sur la cladribine et annonce une initiative de financement Placement Privé BioNxt Solutions Inc. Sclérose En Plaques Programme Cladribine Développement Pharmaceutique
PRESS RELEASE published on 04/26/2024 at 05:50, 4 months 23 days ago Bionxt Solutions Announces Odf Cladribine Update and Financing BioNxt Solutions Inc. advances Cladribine program to human bioavailability studies in Europe, targeting MS market. Announces private placement for research and development Private Placement BioNxt Solutions Inc. Cladribine Program Bioavailability Studies Multiple Sclerosis Market
BRIEF published on 03/18/2024 at 08:10, 6 months 1 day ago BioNxt progresse vers des essais sur l'homme avec la cladribine ODF pour le traitement de la SEP BioNxt Solutions Inc. Essais Cliniques Sclérose En Plaques Technologie D'administration De Médicaments Marché Pharmaceutique
BRIEF published on 03/18/2024 at 08:10, 6 months 1 day ago BioNxt Advances Towards Human Trials with ODF Cladribine for MS Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Drug Delivery Technology Pharmaceutical Market
Published on 09/19/2024 at 19:00, 15 minutes ago Central Bank of Bahrain Grants Crypto.com Payment Service Provider Licence
Published on 09/19/2024 at 19:00, 15 minutes ago Central Bank of Bahrain Grants Crypto.com Payment Service Provider Licence
Published on 09/19/2024 at 17:30, 1 hour 45 minutes ago Airborne Geophysical Survey Completed at Pine Channel Gold Project, Saskatchewan
Published on 09/19/2024 at 17:00, 2 hours 15 minutes ago Cypress Creek Consulting Advises Charter Communications on Inaugural Securitization Financing Facility
Published on 09/19/2024 at 15:45, 3 hours 30 minutes ago eLearners Make eLearning a Daily or Weekly Habit, Voices' eLearning Report Finds
Published on 09/19/2024 at 18:44, 30 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/19/2024 at 18:03, 1 hour 12 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/19/2024 at 17:52, 1 hour 22 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 1 hour 22 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:52, 1 hour 23 minutes ago EQS-Adhoc: SMT Scharf AG: New CEO joins the Managing Board
Published on 09/19/2024 at 17:45, 1 hour 30 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 1 hour 30 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 1 hour 30 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)